SciELO - Scientific Electronic Library Online

 
vol.24 issue4Temporomandibular disorders in the stomatognathic system of the elderly patient author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Archivo Médico de Camagüey

On-line version ISSN 1025-0255

Abstract

CHAVEZ-PARDO, Iris et al. Results of the cicatrization with bevacizumab in the age-related humid macular degeneration. AMC [online]. 2020, vol.24, n.4, e7261.  Epub Aug 01, 2020. ISSN 1025-0255.

Background:

the age-related macular degeneration is among the most common causes of harsh and irreversible visual loss in patient elders of 60 years in the industrialized world. Considering the increase of life expectancy and the rise in population of the senior citizens, the need of an early and opportune diagnosis, it is obvious for this disease that constitutes a health problem we have to solve.

Objective:

to describe the results of the cicatrization with the use of the bevacizumab in the age-related humid macular degeneration.

Methods:

a descriptive, longitudinal study in patients with the diagnosis of age-related humid macular degeneration was carried out. 25 patients that attended the retinal consultation in the period October, 2018 to April, 2019 and who fulfilled the criteria constituted the population of selection. They were applied an opinion poll and they studied variables were: Age, sex, pathological personal background, number of intravitreous injections placed to each patient, complications after injection and cicatrization of the macular injury. B

Results:

according to the age groups and the sex, it was shown that the age between 60 and 69, ten patients and the feminine sex 15 patients were the most frequent. The ocular hypertension was the complication that predominated with four patients. The greatest amount of eyes healed with the administration of one and two doses of the medication.

Conclusions:

the age group from 60 to 69 years and the feminine sex predominated. The ocular hypertension was the most frequent complication. It was verified high blood pressure as the most frequent pathological antecedent. The cicatrization of the eyes happened with the administration between one and two doses.

Keywords : MACULAR DEGENERATION/diagnosis; BEVACIZUMAB/therapeutic use; WOUND HEALING/drug effects; INTRAVITREAL INJECTIONS; OCULAR HYPERTENSION/complications.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )